- Home
- CRMT vs CRDF Comparison
CRMT vs CRDF Comparison
Compare CRMT & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMT
- CRDF
- Stock Information
- Founded
- CRMT 1981
- CRDF 1999
- Country
- CRMT United States
- CRDF United States
- Employees
- CRMT N/A
- CRDF N/A
- Industry
- CRMT Other Specialty Stores
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRMT Consumer Discretionary
- CRDF Health Care
- Exchange
- CRMT Nasdaq
- CRDF Nasdaq
- Market Cap
- CRMT 303.2M
- CRDF 288.7M
- IPO Year
- CRMT N/A
- CRDF N/A
- Fundamental
- Price
- CRMT $44.27
- CRDF $4.75
- Analyst Decision
- CRMT Hold
- CRDF Strong Buy
- Analyst Count
- CRMT 3
- CRDF 3
- Target Price
- CRMT $50.00
- CRDF $10.33
- AVG Volume (30 Days)
- CRMT 65.3K
- CRDF 971.7K
- Earning Date
- CRMT 03-06-2025
- CRDF 02-27-2025
- Dividend Yield
- CRMT N/A
- CRDF N/A
- EPS Growth
- CRMT N/A
- CRDF N/A
- EPS
- CRMT N/A
- CRDF N/A
- Revenue
- CRMT $1,357,351,000.00
- CRDF $688,000.00
- Revenue This Year
- CRMT N/A
- CRDF $25.03
- Revenue Next Year
- CRMT $4.33
- CRDF N/A
- P/E Ratio
- CRMT N/A
- CRDF N/A
- Revenue Growth
- CRMT N/A
- CRDF 49.57
- 52 Week Low
- CRMT $37.98
- CRDF $1.65
- 52 Week High
- CRMT $74.10
- CRDF $6.42
- Technical
- Relative Strength Index (RSI)
- CRMT 33.02
- CRDF 62.77
- Support Level
- CRMT $47.47
- CRDF $4.12
- Resistance Level
- CRMT $52.40
- CRDF $4.38
- Average True Range (ATR)
- CRMT 2.03
- CRDF 0.38
- MACD
- CRMT -0.42
- CRDF 0.04
- Stochastic Oscillator
- CRMT 3.73
- CRDF 80.17
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in us focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The Company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It primarily sells older model used vehicles and provides financing for substantially all of its customers. The Company earns revenue from the sale of used vehicles and in most cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").